دورية أكاديمية

Phase 1/2 Trial of Carfilzomib Plus High-Dose Melphalan Preparative Regimen for Salvage Autologous Hematopoietic Cell Transplantation Followed by Maintenance Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma

التفاصيل البيبلوغرافية
العنوان: Phase 1/2 Trial of Carfilzomib Plus High-Dose Melphalan Preparative Regimen for Salvage Autologous Hematopoietic Cell Transplantation Followed by Maintenance Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma
المؤلفون: Costa, Luciano J. *, Landau, Heather J., Chhabra, Saurabh, Hari, Parameswaran, Innis-Shelton, Racquel, Godby, Kelly N., Hamadani, Mehdi, Tamari, Roni, Anderton, Kate, Dixon, Pamela, Giralt, Sergio A.
المصدر: In Biology of Blood and Marrow Transplantation July 2018 24(7):1379-1385
قاعدة البيانات: ScienceDirect
الوصف
تدمد:10838791
DOI:10.1016/j.bbmt.2018.01.036